Thomas Chen's most recent trade in NeOnc Technologies Holdings Inc. was a trade of 5,556 Common Stock done at an average price of $3.6 . Disclosure was reported to the exchange on Sept. 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 11 Sep 2026 | 5,556 | 19,261 | - | 3.6 | 20,002 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.81 per share. | 11 Sep 2026 | 5,242 | 24,503 | - | 3.8 | 19,998 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.49 per share. | 18 Aug 2026 | 12,757 | 13,705 | - | 5.5 | 69,998 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 10 Apr 2026 | 33,787 | 581,059 | - | 3.8 | 130,002 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.80 per share. | 10 Apr 2026 | 10,000 | 10,000 | - | 4.8 | 48,000 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 10 Apr 2026 | 2,472 | 583,531 | - | 4.0 | 9,998 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.17 per share. | 10 Apr 2026 | 948 | 948 | - | 5.2 | 4,899 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.85 per share. | 09 Apr 2026 | 33,787 | 581,059 | - | 3.8 | 130,002 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 09 Apr 2026 | 2,472 | 583,531 | - | 4.0 | 9,998 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.25 per share. | 21 May 2025 | 2,759 | 548,959 | - | 7.2 | 20,002 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.38 per share. | 21 May 2025 | 2,709 | 551,668 | - | 7.4 | 20,000 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.00 per share. | 12 May 2025 | 400 | 546,200 | - | 7 | 2,800 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | 26 Mar 2025 | 79,688 | 0 | - | - | Warrant (right to buy) | ||
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | 26 Mar 2025 | 79,688 | 300,475 | - | 12 | 956,256 | Common Stock | |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | 26 Mar 2025 | 79,688 | 0 | - | - | Warrant (right to buy) | ||
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | 26 Mar 2025 | 79,688 | 300,475 | - | 12 | 956,256 | Common Stock | |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 26 Mar 2025 | 38,250 | 262,225 | - | 25 | 956,250 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 26 Mar 2025 | 38,250 | 262,225 | - | 25 | 956,250 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 26 Mar 2025 | 4,076 | 220,787 | - | 0 | Common Stock | |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 26 Mar 2025 | 4,076 | 220,787 | - | 0 | Common Stock | |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 26 Mar 2025 | 4,076 | 220,787 | - | 0 | Common Stock | |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.13 per share. | 26 Mar 2025 | 983 | 261,242 | - | 19.1 | 18,805 | Common Stock |
| NeOnc Tech Holdings Inc | Dr. Thomas Chen, M.D.,PhD | Director, CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 19.13 per share. | 26 Mar 2025 | 983 | 261,242 | - | 19.1 | 18,805 | Common Stock |
| Stericycle Inc | Thomas F. Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 3,524 | 3,524 | - | - | Restricted Stock Units | |
| Stericycle Inc | Thomas F. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 3,620 | 20,303 (0%) | 0% | 0 | Common Stock | |
| Stericycle Inc | Thomas F. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 3,620 | 0 | - | - | Restricted Stock Units | |
| Stericycle Inc | Thomas F. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2023 | 2,928 | 0 | - | - | Restricted Stock Units | |
| Stericycle Inc | Thomas F. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2023 | 2,928 | 16,683 (0%) | 0% | - | Common Stock | |
| Stericycle Inc | Thomas F. Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2023 | 3,620 | 3,620 | - | - | Restricted Stock Units | |
| Stericycle Inc | Thomas F. Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 2,928 | 2,928 | - | - | Restricted Stock Units | |
| Stericycle Inc | Thomas F. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 1,837 | 13,755 (0%) | 0% | - | Common Stock | |
| Stericycle Inc | Thomas F. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 1,837 | 0 | - | - | Restricted Stock Units | |
| Baxter International | Mr. Thomas F. Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 15,740 (0%) | 0% | 0 | Common Stock, $1 par value | |
| Baxter International | Mr. Thomas F. Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 2,706 | 15,740 (0%) | 0% | 0 | - | |
| Baxter International | Mr. Thomas F. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.03 per share. | 02 Feb 2022 | 1,680 | 14,667 (0%) | 0% | 35.0 | 58,850 | Common Stock, $1 par value |
| Baxter International | Mr. Thomas F. Chen | Director | 02 Feb 2022 | 1,680 | 0 | - | - | Stock Option (Right to Buy) | ||
| Baxter International | Mr. Thomas F. Chen | Director | Sale of securities on an exchange or to another person at price $ 84.53 per share. | 02 Feb 2022 | 1,680 | 12,987 (0%) | 0% | 84.5 | 142,010 | Common Stock, $1 par value |